Thus, by analogy with the terminal differentiation program of normal B-cells into plasma cells, CLL B-cells increased their STAT3, IRF4, XBP1s and BLIMP1 expression and decreased their c-MYC, PAX5, BCL6, IRF8 and BACH2 expression. Here, BACH2 is linked to B-cell chronic lymphocytic leukemia.